Ribeiro Ramiro 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Ribeiro Ramiro
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2025-01-03+59,000→ 59,000 totalExercise: $0.00→ Common Stock (59,000 underlying) - Award
Stock Option (Right to Buy)
2025-01-03+117,000→ 117,000 totalExercise: $8.26Exp: 2035-01-03→ Common Stock (117,000 underlying)
Footnotes (2)
- [F1]The restricted stock units will vest in three ratable annual installments beginning January 3, 2026.
- [F2]The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.